Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 6 of 6 entries
View as:

A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT05359133 Org: User:
Start: 04/19/22 End: 10/14/24 Due: 10/14/25

The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01655823 Org: User:
Start: 07/31/12 End: 02/11/15 Due: 02/11/16

Comparison Study of Liquid and Lyophilized Formulations of Subcutaneous Tetrodotoxin (TTX) in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01527734 Org: User:
Start: 12/31/11 End: - Due: -

Tetrodotoxin Open-label Efficacy and Safety Continuation Study

Phase: N/A Priority: Normal
NCT ID: NCT00726011 Org: User:
Start: 07/31/08 End: 07/31/12 Due: 07/31/13

A Phase 1, Single Ascending Dose, Randomized, Double-Blind, Placebo and Positive Controlled Study to Evaluate the Cardiovascular Effect of Tetrodotoxin in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04083833 Org: User:
Start: 02/07/18 End: 03/24/18 Due: 03/24/19

Safety & Efficacy Study of Subcutaneous Tetrodotoxin for Moderate to Severe Inadequately Controlled Cancer-related Pain

Phase: N/A Priority: Normal
NCT ID: NCT00725114 Org: User:
Start: 04/30/08 End: 11/30/12 Due: 11/30/13